VIAF

Virtual International Authority File

Search

Leader     00000nz a2200037n 45 0
001     WKP|Q40077215  (VIAF cluster)  (Authority/Source Record)
003     WKP
005     20241120235755.0
008     241120nneanz||abbn n and d
035 ‎‡a  (WKP)Q40077215‏
024 ‎‡a  0000-0002-9315-5321‏ ‎‡2  orcid‏
035 ‎‡a  (OCoLC)Q40077215‏
100 0 ‎‡a  Alex Thompson‏ ‎‡c  investigador‏ ‎‡9  ast‏
375 ‎‡a  1‏ ‎‡2  iso5218‏
400 0 ‎‡a  অ্যালেক্স টম্পসন‏ ‎‡c  গবেষক‏ ‎‡9  bn‏
400 0 ‎‡a  Alex Thompson‏ ‎‡c  researcher‏ ‎‡9  en‏
400 0 ‎‡a  Alex Thompson‏ ‎‡c  investigador‏ ‎‡9  es‏
400 0 ‎‡a  Alex Thompson‏ ‎‡c  ricercatore‏ ‎‡9  it‏
400 0 ‎‡a  Alex Thompson‏ ‎‡c  wetenschapper‏ ‎‡9  nl‏
670 ‎‡a  Author's A New Transgenic Mouse Model for the Study of Cell Cycle Control in Megakaryocytes‏
670 ‎‡a  Author's AINT/ERIC/TACC: an expanding family of proteins with C-terminal coiled coil domains.‏
670 ‎‡a  Author's Analysis of HSC activity and compensatory Hox gene expression profile in Hoxb cluster mutant fetal liver cells‏
670 ‎‡a  Author's c-Met inhibition in a HOXA9/Meis1 model of CN-AML.‏
670 ‎‡a  Author's Characterization and localization of expression of an erythropoietin-induced gene, ERIC-1/TACC3, identified in erythroid precursor cells‏
670 ‎‡a  Author's Complete array of HOX gene expression by RQ-PCR.‏
670 ‎‡a  Author's Continuous MLL-ENL expression is necessary to establish a "Hox Code" and maintain immortalization of hematopoietic progenitor cells‏
670 ‎‡a  Author's Correlation of TACC3, FGFR3, MMSET and p21 expression with the t(4;14)(p16.3;q32) in multiple myeloma‏
670 ‎‡a  Author's Decitabine-Vorinostat combination treatment in acute myeloid leukemia activates pathways with potential for novel triple therapy‏
670 ‎‡a  Author's Deregulated expression of c-myc in megakaryocytes of transgenic mice increases megakaryopoiesis and decreases polyploidization.‏
670 ‎‡a  Author's Differential Hox expression in murine embryonic stem cell models of normal and malignant hematopoiesis.‏
670 ‎‡a  Author's Effects of nitric oxide inhibition on systemic and renal hemodynamics in the hemorrhaged rat‏
670 ‎‡a  Author's Endothelin receptor A blockade alters hemodynamic response to nitric oxide inhibition in rats‏
670 ‎‡a  Author's Entinostat prevents leukemia maintenance in a collaborating oncogene-dependent model of cytogenetically normal acute myeloid leukemia‏
670 ‎‡a  Author's Global down-regulation of HOX gene expression in PML-RARalpha + acute promyelocytic leukemia identified by small-array real-time PCR.‏
670 ‎‡a  Author's Grappling with the HOX network in hematopoiesis and leukemia.‏
670 ‎‡a  Author's High incidence of proviral integrations in the Hoxa locus in a new model of E2a-PBX1-induced B-cell leukemia.‏
670 ‎‡a  Author's HOX genes in normal, engineered and malignant hematopoiesis‏
670 ‎‡a  Author's Hoxa cluster genes determine the proliferative activity of adult mouse hematopoietic stem and progenitor cells.‏
670 ‎‡a  Author's HoxA cluster is haploinsufficient for activity of hematopoietic stem and progenitor cells‏
670 ‎‡a  Author's HOXA/PBX3 knockdown impairs growth and sensitizes cytogenetically normal acute myeloid leukemia cells to chemotherapy‏
670 ‎‡a  Author's Hoxa6 potentiates short-term hemopoietic cell proliferation and extended self-renewal.‏
670 ‎‡a  Author's Hoxa9 collaborates with E2A-PBX1 in mouse B cell leukemia in association with Flt3 activation and decrease of B cell gene expression‏
670 ‎‡a  Author's Inhibition of HOX/PBX dimer formation leads to necroptosis in acute myeloid leukemia cells‏
670 ‎‡a  Author's Integrated analysis of the molecular action of Vorinostat identifies epi-sensitised targets for combination therapy.‏
670 ‎‡a  Author's Low-dose salinomycin induces anti-leukemic responses in AML and MLL.‏
670 ‎‡a  Author's Molecular dissection of Meis1 reveals 2 domains required for leukemia induction and a key role for Hoxa gene activation‏
670 ‎‡a  Author's Overexpression of cyclin D1 moderately increases ploidy in megakaryocytes‏
670 ‎‡a  Author's POU2F1 activity regulates HOXD10 and HOXD11 promoting a proliferative and invasive phenotype in head and neck cancer‏
670 ‎‡a  Author's Prolonged molecular remission in PML-RARalpha-positive acute promyelocytic leukemia treated with minimal chemotherapy followed by maintenance including the histone deacetylase inhibitor sodium valproate‏
670 ‎‡a  Author's Protein arginine-methyltransferase-dependent oncogenesis‏
670 ‎‡a  Author's Quantification of Hox and surfactant protein-B transcription during murine lung development.‏
670 ‎‡a  Author's Rational drug repurposing using sscMap analysis in a HOX-TALE model of leukemia.‏
670 ‎‡a  Author's Repression of A TAF‏
670 ‎‡a  Author's Repression of A TAF(II)32 isoform as part of a program of genes regulated during mpl ligand-induced megakaryocyte differentiation‏
670 ‎‡a  Author's Signaling by the Mpl receptor involves IKK and NF-kappaB.‏
670 ‎‡a  Author's Stroma-free hemoglobin increases blood pressure and GFR in the hypotensive rat: role of nitric oxide‏
670 ‎‡a  Author's Targeted deletion of the Hoxa cluster affects B lymphopoiesis through depletion of early lymphoid progenitors.‏
670 ‎‡a  Author's The histone deacetylase inhibitor Romidepsin induces as a cascade of differential gene expression and altered histone H3K9 marks in myeloid leukaemia cells‏
670 ‎‡a  Author's The pathophysiology of HOX genes and their role in cancer.‏
670 ‎‡a  Author's Three-dimensional ex vivo co-culture models of the leukaemic bone marrow niche for functional drug testing‏
670 ‎‡a  Author's Thrombopoietin, flt3-ligand and c-kit-ligand modulate HOX gene expression in expanding cord blood CD133 cells‏
670 ‎‡a  Author's Variable expression and silencing of CRISPR-Cas9 targeted transgenes identifies the AAVS1 locus as not an entirely safe harbour‏
909 ‎‡a  (orcid) 0000000293155321‏ ‎‡9  1‏
919 ‎‡a  pou2f1activityregulateshoxd10andhoxd11promotingaproliferativeandinvasivephenotypeinheadandneckcancer‏ ‎‡A  POU2F1 activity regulates HOXD10 and HOXD11 promoting a proliferative and invasive phenotype in head and neck cancer‏ ‎‡9  1‏
919 ‎‡a  overexpressionofcyclind1moderatelyincreasesploidyinmegakaryocytes‏ ‎‡A  Overexpression of cyclin D1 moderately increases ploidy in megakaryocytes‏ ‎‡9  1‏
919 ‎‡a  moleculardissectionofmeis1reveals2domainsrequiredforleukemiainductionandakeyroleforhoxageneactivation‏ ‎‡A  Molecular dissection of Meis1 reveals 2 domains required for leukemia induction and a key role for Hoxa gene activation‏ ‎‡9  1‏
919 ‎‡a  lowdosesalinomycininducesantileukemicresponsesinamlandmll‏ ‎‡A  Low-dose salinomycin induces anti-leukemic responses in AML and MLL.‏ ‎‡9  1‏
919 ‎‡a  integratedanalysisofthemolecularactionofvorinostatidentifiesepisensitisedtargetsforcombinationtherapy‏ ‎‡A  Integrated analysis of the molecular action of Vorinostat identifies epi-sensitised targets for combination therapy.‏ ‎‡9  1‏
919 ‎‡a  inhibitionofhoxpbxdimerformationleadstonecroptosisinacutemyeloidleukemiacells‏ ‎‡A  Inhibition of HOX/PBX dimer formation leads to necroptosis in acute myeloid leukemia cells‏ ‎‡9  1‏
919 ‎‡a  hoxa9collaborateswithe2apbx1inmousebcellleukemiainassociationwithflt3activationanddecreaseofbcellgeneexpression‏ ‎‡A  Hoxa9 collaborates with E2A-PBX1 in mouse B cell leukemia in association with Flt3 activation and decrease of B cell gene expression‏ ‎‡9  1‏
919 ‎‡a  hoxa6potentiatesshorttermhemopoieticcellproliferationandextendedselfrenewal‏ ‎‡A  Hoxa6 potentiates short-term hemopoietic cell proliferation and extended self-renewal.‏ ‎‡9  1‏
919 ‎‡a  hoxapbx3knockdownimpairsgrowthandsensitizescytogeneticallynormalacutemyeloidleukemiacellstochemotherapy‏ ‎‡A  HOXA/PBX3 knockdown impairs growth and sensitizes cytogenetically normal acute myeloid leukemia cells to chemotherapy‏ ‎‡9  1‏
919 ‎‡a  hoxaclusterishaploinsufficientforactivityofhematopoieticstemandprogenitorcells‏ ‎‡A  HoxA cluster is haploinsufficient for activity of hematopoietic stem and progenitor cells‏ ‎‡9  1‏
919 ‎‡a  hoxaclustergenesdeterminetheproliferativeactivityofadultmousehematopoieticstemandprogenitorcells‏ ‎‡A  Hoxa cluster genes determine the proliferative activity of adult mouse hematopoietic stem and progenitor cells.‏ ‎‡9  1‏
919 ‎‡a  hoxgenesinnormalengineeredandmalignanthematopoiesis‏ ‎‡A  HOX genes in normal, engineered and malignant hematopoiesis‏ ‎‡9  1‏
919 ‎‡a  highincidenceofproviralintegrationsinthehoxalocusinanewmodelofe2apbx1inducedbcellleukemia‏ ‎‡A  High incidence of proviral integrations in the Hoxa locus in a new model of E2a-PBX1-induced B-cell leukemia.‏ ‎‡9  1‏
919 ‎‡a  grapplingwiththehoxnetworkinhematopoiesisandleukemia‏ ‎‡A  Grappling with the HOX network in hematopoiesis and leukemia.‏ ‎‡9  1‏
919 ‎‡a  globaldownregulationofhoxgeneexpressioninpmlraralpha+acutepromyelocyticleukemiaidentifiedbysmallarrayrealtimepcr‏ ‎‡A  Global down-regulation of HOX gene expression in PML-RARalpha + acute promyelocytic leukemia identified by small-array real-time PCR.‏ ‎‡9  1‏
919 ‎‡a  entinostatpreventsleukemiamaintenanceinacollaboratingoncogenedependentmodelofcytogeneticallynormalacutemyeloidleukemia‏ ‎‡A  Entinostat prevents leukemia maintenance in a collaborating oncogene-dependent model of cytogenetically normal acute myeloid leukemia‏ ‎‡9  1‏
919 ‎‡a  endothelinreceptorablockadealtershemodynamicresponsetonitricoxideinhibitioninrats‏ ‎‡A  Endothelin receptor A blockade alters hemodynamic response to nitric oxide inhibition in rats‏ ‎‡9  1‏
919 ‎‡a  effectsofnitricoxideinhibitiononsystemicandrenalhemodynamicsinthehemorrhagedrat‏ ‎‡A  Effects of nitric oxide inhibition on systemic and renal hemodynamics in the hemorrhaged rat‏ ‎‡9  1‏
919 ‎‡a  differentialhoxexpressioninmurineembryonicstemcellmodelsofnormalandmalignanthematopoiesis‏ ‎‡A  Differential Hox expression in murine embryonic stem cell models of normal and malignant hematopoiesis.‏ ‎‡9  1‏
919 ‎‡a  deregulatedexpressionof100mycinmegakaryocytesoftransgenicmiceincreasesmegakaryopoiesisanddecreasespolyploidization‏ ‎‡A  Deregulated expression of c-myc in megakaryocytes of transgenic mice increases megakaryopoiesis and decreases polyploidization.‏ ‎‡9  1‏
919 ‎‡a  decitabinevorinostatcombinationtreatmentinacutemyeloidleukemiaactivatespathwayswithpotentialfornoveltripletherapy‏ ‎‡A  Decitabine-Vorinostat combination treatment in acute myeloid leukemia activates pathways with potential for novel triple therapy‏ ‎‡9  1‏
919 ‎‡a  correlationoftacc3fgfr3mmsetandp21expressionwiththet414p163q32inmultiplemyeloma‏ ‎‡A  Correlation of TACC3, FGFR3, MMSET and p21 expression with the t(4;14)(p16.3;q32) in multiple myeloma‏ ‎‡9  1‏
919 ‎‡a  continuousmllenlexpressionisnecessarytoestablishahoxcodeandmaintainimmortalizationofhematopoieticprogenitorcells‏ ‎‡A  Continuous MLL-ENL expression is necessary to establish a "Hox Code" and maintain immortalization of hematopoietic progenitor cells‏ ‎‡9  1‏
919 ‎‡a  completearrayofhoxgeneexpressionbyrqpcr‏ ‎‡A  Complete array of HOX gene expression by RQ-PCR.‏ ‎‡9  1‏
919 ‎‡a  characterizationandlocalizationofexpressionofanerythropoietininducedgeneeric1tacc3identifiedinerythroidprecursorcells‏ ‎‡A  Characterization and localization of expression of an erythropoietin-induced gene, ERIC-1/TACC3, identified in erythroid precursor cells‏ ‎‡9  1‏
919 ‎‡a  100metinhibitioninahoxa9meis1modelofcnaml‏ ‎‡A  c-Met inhibition in a HOXA9/Meis1 model of CN-AML.‏ ‎‡9  1‏
919 ‎‡a  analysisofhscactivityandcompensatoryhoxgeneexpressionprofileinhoxbclustermutantfetallivercells‏ ‎‡A  Analysis of HSC activity and compensatory Hox gene expression profile in Hoxb cluster mutant fetal liver cells‏ ‎‡9  1‏
919 ‎‡a  ainterictaccanexpandingfamilyofproteinswith100terminalcoiledcoildomains‏ ‎‡A  AINT/ERIC/TACC: an expanding family of proteins with C-terminal coiled coil domains.‏ ‎‡9  1‏
919 ‎‡a  newtransgenicmousemodelforthestudyofcellcyclecontrolinmegakaryocytes‏ ‎‡A  A New Transgenic Mouse Model for the Study of Cell Cycle Control in Megakaryocytes‏ ‎‡9  1‏
919 ‎‡a  variableexpressionandsilencingofcrisprcas9targetedtransgenesidentifiestheaavs1locusasnotanentirelysafeharbour‏ ‎‡A  Variable expression and silencing of CRISPR-Cas9 targeted transgenes identifies the AAVS1 locus as not an entirely safe harbour‏ ‎‡9  1‏
919 ‎‡a  thrombopoietinflt3ligandand100kitligandmodulatehoxgeneexpressioninexpandingcordbloodcd133cells‏ ‎‡A  Thrombopoietin, flt3-ligand and c-kit-ligand modulate HOX gene expression in expanding cord blood CD133 cells‏ ‎‡9  1‏
919 ‎‡a  3dimensionalexvivococulturemodelsoftheleukaemicbonemarrownicheforfunctionaldrugtesting‏ ‎‡A  Three-dimensional ex vivo co-culture models of the leukaemic bone marrow niche for functional drug testing‏ ‎‡9  1‏
919 ‎‡a  pathophysiologyofhoxgenesandtheirroleincancer‏ ‎‡A  The pathophysiology of HOX genes and their role in cancer.‏ ‎‡9  1‏
919 ‎‡a  histonedeacetylaseinhibitorromidepsininducesasacascadeofdifferentialgeneexpressionandalteredhistoneh3k9marksinmyeloidleukaemiacells‏ ‎‡A  The histone deacetylase inhibitor Romidepsin induces as a cascade of differential gene expression and altered histone H3K9 marks in myeloid leukaemia cells‏ ‎‡9  1‏
919 ‎‡a  targeteddeletionofthehoxaclusteraffectsblymphopoiesisthroughdepletionofearlylymphoidprogenitors‏ ‎‡A  Targeted deletion of the Hoxa cluster affects B lymphopoiesis through depletion of early lymphoid progenitors.‏ ‎‡9  1‏
919 ‎‡a  stromafreehemoglobinincreasesbloodpressureandgfrinthehypotensiveratroleofnitricoxide‏ ‎‡A  Stroma-free hemoglobin increases blood pressure and GFR in the hypotensive rat: role of nitric oxide‏ ‎‡9  1‏
919 ‎‡a  signalingbythemplreceptorinvolvesikkandnfkappab‏ ‎‡A  Signaling by the Mpl receptor involves IKK and NF-kappaB.‏ ‎‡9  1‏
919 ‎‡a  repressionofataf232isoformaspartofaprogramofgenesregulatedduringmplligandinducedmegakaryocytedifferentiation‏ ‎‡A  Repression of A TAF(II)32 isoform as part of a program of genes regulated during mpl ligand-induced megakaryocyte differentiation‏ ‎‡9  1‏
919 ‎‡a  repressionofataf‏ ‎‡A  Repression of A TAF‏ ‎‡9  1‏
919 ‎‡a  rationaldrugrepurposingusingsscmapanalysisinahoxtalemodelofleukemia‏ ‎‡A  Rational drug repurposing using sscMap analysis in a HOX-TALE model of leukemia.‏ ‎‡9  1‏
919 ‎‡a  quantificationofhoxandsurfactantproteinbtranscriptionduringmurinelungdevelopment‏ ‎‡A  Quantification of Hox and surfactant protein-B transcription during murine lung development.‏ ‎‡9  1‏
919 ‎‡a  proteinargininemethyltransferasedependentoncogenesis‏ ‎‡A  Protein arginine-methyltransferase-dependent oncogenesis‏ ‎‡9  1‏
919 ‎‡a  prolongedmolecularremissioninpmlraralphapositiveacutepromyelocyticleukemiatreatedwithminimalchemotherapyfollowedbymaintenanceincludingthehistonedeacetylaseinhibitorsodiumvalproate‏ ‎‡A  Prolonged molecular remission in PML-RARalpha-positive acute promyelocytic leukemia treated with minimal chemotherapy followed by maintenance including the histone deacetylase inhibitor sodium valproate‏ ‎‡9  1‏
946 ‎‡a  b‏ ‎‡9  1‏
996 ‎‡2  CAOONL|ncf10239828‏
996 ‎‡2  LC|no2023109886‏
996 ‎‡2  NLA|000035547182‏
996 ‎‡2  BNE|XX1714252‏
996 ‎‡2  SUDOC|262687003‏
996 ‎‡2  ISNI|0000000074046301‏
996 ‎‡2  J9U|987010326785805171‏
996 ‎‡2  LC|nb2013000149‏
996 ‎‡2  SUDOC|108093948‏
996 ‎‡2  SUDOC|245396403‏
996 ‎‡2  ISNI|0000000010786490‏
996 ‎‡2  ISNI|0000000028954931‏
996 ‎‡2  LC|no2008175022‏
996 ‎‡2  ISNI|0000000118570114‏
996 ‎‡2  DNB|128362405‏
996 ‎‡2  ISNI|0000000067803247‏
996 ‎‡2  BAV|495_293561‏
996 ‎‡2  PTBNP|188442‏
996 ‎‡2  ISNI|0000000408276597‏
996 ‎‡2  LC|no2007155781‏
996 ‎‡2  SUDOC|079857817‏
996 ‎‡2  N6I|vtls002816654‏
996 ‎‡2  DNB|1283032422‏
996 ‎‡2  LC|no2015012194‏
996 ‎‡2  DNB|1273496108‏
996 ‎‡2  BIBSYS|90545567‏
996 ‎‡2  BIBSYS|90940566‏
996 ‎‡2  LC|n 87854620‏
996 ‎‡2  DNB|1211651002‏
996 ‎‡2  ISNI|0000000053968462‏
996 ‎‡2  BIBSYS|90080944‏
996 ‎‡2  ISNI|0000000078906380‏
996 ‎‡2  J9U|987007317302405171‏
996 ‎‡2  J9U|987007339956405171‏
996 ‎‡2  CAOONL|ncf13699268‏
996 ‎‡2  CAOONL|ncf10592495‏
996 ‎‡2  LC|n 88645524‏
996 ‎‡2  J9U|987011288930905171‏
996 ‎‡2  LC|no2008154733‏
996 ‎‡2  J9U|987007397293805171‏
996 ‎‡2  DNB|1207417025‏
996 ‎‡2  NUKAT|n 2005096099‏
996 ‎‡2  LC|nb2015008502‏
996 ‎‡2  NKC|mzk20211108581‏
996 ‎‡2  J9U|987007385931105171‏
996 ‎‡2  LC|n 82156752‏
996 ‎‡2  LC|no2022088184‏
996 ‎‡2  SUDOC|193123355‏
996 ‎‡2  CAOONL|ncf11539119‏
996 ‎‡2  NUKAT|n 2004013021‏
996 ‎‡2  LC|nb2011019854‏
996 ‎‡2  BNE|XX1109875‏
996 ‎‡2  DNB|170862550‏
996 ‎‡2  J9U|987009761485305171‏
996 ‎‡2  BIBSYS|4078263‏
996 ‎‡2  PLWABN|9810549621105606‏
996 ‎‡2  ISNI|0000000051030585‏
996 ‎‡2  N6I|vtls000304775‏
996 ‎‡2  BIBSYS|90531851‏
996 ‎‡2  LC|no2008042649‏
996 ‎‡2  SUDOC|279348703‏
996 ‎‡2  J9U|987007435935505171‏
996 ‎‡2  PTBNP|1371221‏
996 ‎‡2  LC|nb2018010531‏
996 ‎‡2  J9U|987007327671505171‏
996 ‎‡2  LC|n 2010040948‏
996 ‎‡2  DNB|141355352‏
996 ‎‡2  LC|no2011067436‏
996 ‎‡2  ISNI|0000000109001534‏
996 ‎‡2  DNB|123108698X‏
996 ‎‡2  LC|nr 98042639‏
996 ‎‡2  ISNI|0000000119466239‏
996 ‎‡2  LC|nb2006014786‏
996 ‎‡2  N6I|vtls001360815‏
996 ‎‡2  LC|nb2019024309‏
996 ‎‡2  JPG|500435862‏
996 ‎‡2  ISNI|0000000119378255‏
996 ‎‡2  BIBSYS|90966919‏
996 ‎‡2  SUDOC|084672692‏
996 ‎‡2  N6I|vtls001284186‏
996 ‎‡2  PLWABN|9813704807805606‏
996 ‎‡2  DNB|101574738‏
996 ‎‡2  NUKAT|nx2023355231‏
996 ‎‡2  LC|n 50008810‏
996 ‎‡2  ISNI|0000000067988755‏
996 ‎‡2  SUDOC|267380461‏
996 ‎‡2  PLWABN|9811773140405606‏
996 ‎‡2  BNE|XX5740833‏
996 ‎‡2  NTA|069838003‏
996 ‎‡2  SUDOC|09193365X‏
996 ‎‡2  LC|n 2022015424‏
996 ‎‡2  ISNI|0000000498794995‏
996 ‎‡2  RERO|A013831593‏
996 ‎‡2  LC|nb2003114263‏
996 ‎‡2  LC|no 98070639‏
996 ‎‡2  RERO|A003898105‏
996 ‎‡2  NUKAT|n 2008055726‏
996 ‎‡2  BNF|10656296‏
996 ‎‡2  LC|nb2012026499‏
996 ‎‡2  LC|no 96065110‏
996 ‎‡2  BNCHL|10000000000000000171629‏
996 ‎‡2  LC|n 86034050‏
996 ‎‡2  NKC|skuk0005588‏
996 ‎‡2  LC|no2006026568‏
996 ‎‡2  BIBSYS|90913217‏
996 ‎‡2  ISNI|0000000368522350‏
996 ‎‡2  NTA|070025355‏
996 ‎‡2  CAOONL|ncf11569433‏
996 ‎‡2  NII|DA01469022‏
996 ‎‡2  LC|no2011039295‏
996 ‎‡2  SUDOC|20176508X‏
996 ‎‡2  NUKAT|n 2007102693‏
996 ‎‡2  NLA|000035064532‏
996 ‎‡2  LC|no2023061798‏
996 ‎‡2  BIBSYS|90326647‏
996 ‎‡2  LC|n 97086873‏
996 ‎‡2  LC|n 88664657‏
996 ‎‡2  ISNI|0000000084322744‏
996 ‎‡2  BIBSYS|1512647517356‏
996 ‎‡2  BIBSYS|66580‏
996 ‎‡2  LC|n 2019046275‏
996 ‎‡2  N6I|vtls000033807‏
996 ‎‡2  J9U|987007307210105171‏
996 ‎‡2  DNB|1216460558‏
996 ‎‡2  NTA|069246947‏
996 ‎‡2  NUKAT|n 2020215313‏
996 ‎‡2  NUKAT|n 2003071308‏
996 ‎‡2  ISNI|0000000034527389‏
996 ‎‡2  LC|n 79052912‏
996 ‎‡2  ISNI|0000000116601298‏
996 ‎‡2  LC|no2009198005‏
996 ‎‡2  SUDOC|154695408‏
996 ‎‡2  J9U|987007333898705171‏
996 ‎‡2  BIBSYS|90402036‏
996 ‎‡2  DBC|87097969723071‏
996 ‎‡2  BIBSYS|90703570‏
996 ‎‡2  SUDOC|197069134‏
996 ‎‡2  ISNI|0000000033361575‏
996 ‎‡2  NTA|321352092‏
996 ‎‡2  LC|n 90694985‏
996 ‎‡2  LC|nr2001034446‏
996 ‎‡2  LC|no 92014232‏
996 ‎‡2  LC|no2013088252‏
996 ‎‡2  NYNYRILM|278690‏
996 ‎‡2  LC|nb2010000721‏
996 ‎‡2  J9U|987007357380805171‏
996 ‎‡2  LC|no2014009094‏
996 ‎‡2  ISNI|0000000398426247‏
996 ‎‡2  PLWABN|9812480399205606‏
996 ‎‡2  ISNI|0000000076135391‏
996 ‎‡2  ISNI|0000000025480240‏
996 ‎‡2  LC|no2023038393‏
996 ‎‡2  PTBNP|1021409‏
996 ‎‡2  DNB|139425624‏
996 ‎‡2  ISNI|0000000070798477‏
996 ‎‡2  SIMACOB|34620771‏
996 ‎‡2  BNF|16453602‏
996 ‎‡2  ISNI|0000000418380734‏
996 ‎‡2  NII|DA02481533‏
996 ‎‡2  LC|no2005006375‏
996 ‎‡2  SUDOC|120767023‏
996 ‎‡2  ISNI|0000000123514678‏
996 ‎‡2  DNB|1157478204‏
996 ‎‡2  J9U|987007596956705171‏
996 ‎‡2  SUDOC|136501664‏
996 ‎‡2  LC|nr 98008396‏
996 ‎‡2  LC|no2024103424‏
996 ‎‡2  NII|DA14831155‏
996 ‎‡2  DNB|1214618693‏
996 ‎‡2  LC|n 2024045773‏
996 ‎‡2  BNF|18081737‏
996 ‎‡2  JPG|500243086‏
996 ‎‡2  BIBSYS|98025046‏
996 ‎‡2  LC|no2020085224‏
996 ‎‡2  CAOONL|ncf11285597‏
996 ‎‡2  BAV|495_95057‏
996 ‎‡2  DNB|134839110‏
996 ‎‡2  NTA|195006798‏
996 ‎‡2  LC|n 85066422‏
996 ‎‡2  J9U|987007458399305171‏
996 ‎‡2  ISNI|0000000496129334‏
996 ‎‡2  NII|DA08602244‏
996 ‎‡2  BIBSYS|12022915‏
996 ‎‡2  LC|n 92806238‏
996 ‎‡2  N6I|vtls000074548‏
996 ‎‡2  LC|no2006051377‏
996 ‎‡2  ISNI|0000000044187605‏
996 ‎‡2  DNB|173189687‏
996 ‎‡2  RERO|A017396302‏
996 ‎‡2  DNB|137437382‏
996 ‎‡2  LC|n 2016017799‏
996 ‎‡2  LC|n 2017190246‏
996 ‎‡2  LC|no2006052263‏
996 ‎‡2  BNC|981058516929306706‏
997 ‎‡a  0 0 lived 0 0‏ ‎‡9  1‏